This report shows patient survival outcomes and transplant data for bone marrow and cord blood transplants performed at U.S. transplant centers. The report includes data about transplants that are grouped according to these donor types:
- Autologous (the patient’s cells)
- Related allogeneic (a patient's sibling or another family member's cells)
- Unrelated allogeneic (a volunteer donor's cells)
The cells used for a transplant can be from bone marrow, peripheral blood or umbilical cord blood after a baby is born.
Report Available
- U.S. Patient Survival Outcomes Report – View patient survival estimates for a disease and the length of time after transplant: 100 days, 1 year and 3 years. You can also select survival estimates by patient age, patient gender, patient race or cell source.
Reading This Report
For an explanation of words and phrases used in this report, see Glossary for U.S. Transplant Data.
This report includes data provided from January 1, 2000 through December 31, 2005. U.S. transplant centers provided data voluntarily to the National Marrow Donor Program® (NMDP) and the Center for International Blood and Marrow Transplant Research® (CIBMTR). (More transplants to treat a disease may have been done, but the data were not reported to the NMDP or the CIBMTR.)
If the data you need are not available through this report, you can submit a customized data request using a CIBMTR Data Request Form (not a U.S. Government Web site).
